Metanium

Quick links to important sections

Metanium

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Metanium

Property Description
Active Ingredients Titanium Dioxide, Titanium Peroxide, Titanium Salicylate
Form Ointment or Paste
Pharmacological Class Protectant, Barrier Preparation
Common Use Dermo-protection against surface irritation
Origin Primarily synthetic (inorganic metal compounds)

What is Metanium and What is its Pharmacological Class?

Metanium is a specialized pharmaceutical product defined as a proprietary Combination product formulated specifically for Topical (dermal) application, which is widely recognized as an over-the-counter (OTC) medicine. It belongs to the Pharmacological class of Protectants and Barrier Preparations, functioning as a unique dermo-protective, astringent, and mild antiseptic formulation. This ointment is clinically recognized for its ability to create a tenacious physical barrier, distinguishing its protective efficacy for sensitive skin care from standard emollients.

Composition: The Unique Combination of Active Ingredients

The identity of Metanium is established by its three Active ingredients: Titanium Dioxide, Titanium Peroxide, and Titanium Salicylate, which work synergistically. This specific triple-compound formulation provides a multifunctional approach compared to single-ingredient protective formulations. Titanium Dioxide is widely used in pharmaceutical preparations, recognized for its inert nature and ability to create a physical film. The product is physically categorized as an Ointment or Paste, utilizing a specialized hydrophobic Base/vehicle—typically a silicone paraffin base—which is essential for creating the water-repellent film that defines its function.

How Metanium Works as a Dermal Barrier

The preparation operates primarily through Physical Barrier Formation, creating a durable, water-repellent seal that prevents direct skin contact with external irritants and moisture. This core mechanism is complemented by a Dual-action capability: the preparation provides both astringent properties and a mild, localized soothing action from the Titanium Salicylate. The astringent component assists in gently drying the skin surface, while the overall formulation helps to mitigate existing surface discomfort, supporting the maintenance of a cleaner, drier dermal environment.

What side effects are possible with Metanium?

Possible Side Effects and Safety Information

The regulatory safety profile for this topical preparation is primarily characterized by a low incidence of localized adverse reactions, as documented in official government labeling. All factual statements regarding side effects and safety constraints are derived from authoritative regulatory sources.


Official Adverse Reaction Scope

Adverse reactions associated with the use of Metanium are officially classified as Very Rare, meaning they may affect less than 1 in 10,000 people. The documented adverse effects are limited to the Skin and Subcutaneous Tissue Disorders, indicating a highly localized profile.

The only officially listed adverse reaction is Skin irritation at the application site. Regulatory text advises that if any irritation or unusual effects occur, use should be discontinued.


Serious Safety Constraints

This preparation has a formal Contraindication for individuals with a known hypersensitivity or allergy to any of its active or inactive ingredients, including Titanium Dioxide, Titanium Peroxide, and Titanium Salicylate. Hypersensitivity reactions represent the most significant safety constraint documented in official product information.

Safety-Related Restrictions

Official safety notes define specific restrictions for application. The product is strictly for external use only, and should not be used on skin that is severely compromised, specifically skin that is badly cracked, inflamed, or bleeding. There are no unique population-specific warnings beyond the general safety profile stated for infants, which is the primary population of use.

This structure establishes the preparation as having an officially defined, highly localized safety scope, with the key risk factor being pre-existing ingredient allergy.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information indicates that overdose is unlikely when this product is used topically as instructed for nappy rash. The risk of toxicity is linked to the presence of titanium salicylate in the formulation, and symptoms may arise from accidental ingestion or excessive topical application.

Documented Overdose Manifestations

Overdosage may present with signs characteristic of salicylate poisoning. Common features documented in regulatory sources include:

  • Gastrointestinal and Metabolic: Vomiting, dehydration, sweating, hyperpyrexia (fever), and acid-base disturbances (often a mixed respiratory alkalosis and metabolic acidosis).
  • Neurological: Tinnitus, vertigo, deafness, and, less commonly, confusion, disorientation, coma, or convulsions.

Serious or Life-Threatening Outcomes documented include renal failure, non-cardiac pulmonary oedema, and potentially severe poisoning requiring intensive care.

Emergency Response and Management

Immediate medical help must be sought if accidental ingestion or signs of salicylate poisoning are suspected. Regulatory guidelines for management focus on reducing absorption and enhancing elimination:

  • Initial Action: Administration of activated charcoal may be required if ingestion occurs within one hour.
  • Metabolic Management: Treatment often involves urinary alkalinisation and the correction of metabolic acidosis using intravenous sodium bicarbonate.
  • Severe Cases: Haemodialysis is considered the treatment of choice for severe poisoning, particularly in cases with high plasma salicylate concentrations or unmanageable clinical features.

Population Note: Patients under ten years old have an increased risk of salicylate toxicity and may present with a dominant metabolic acidosis.

Therapeutic Uses of Metanium

The use of this specialized barrier preparation is focused entirely on providing essential protection and symptomatic support for specific categories of skin irritation, particularly those driven by moisture, friction, and chemical irritants. This product class is recognized for managing symptoms related to skin inflammation.

Protection and Symptomatic Support for Diaper Dermatitis

This preparation is commonly used to help with symptomatic discomfort and visible skin changes, such as redness (erythema) and superficial tenderness, associated with nappy rash in infants and young children. It offers supportive therapeutic benefit, which may help ease the local symptom burden during acute or recurrent episodes.

Relief for Moisture-Induced Skin Breakdown

Metanium is relevant in situations where symptoms cluster around maceration and chafing, resulting from prolonged fluid exposure or friction in skin folds. The application generally contributes to improved day-to-day comfort and assists with easing the impact of symptoms on routine stability, especially in infants and individuals managing incontinence.

“It is applied in scenarios where additional management of discomfort is required, helping to maintain a sense of stability when symptoms are more noticeable.”


Quick Fact: Relief for Moisture-Induced Skin Discomfort The preparation supports the patient during difficult episodes by easing distress and provides supportive relief in situations involving continued moisture and irritant exposure.


Regulatory References

  1. Health Canada Diaper Rash Products Monograph

Eligibility and Restrictions for Use

Who can and cannot use Metanium?

The population eligibility and non-eligibility rules for Metanium Nappy Rash Ointment are formally defined by regulatory documents, focusing primarily on the product's intended use, allergic status, and the condition of the skin at the application site.

Eligibility Scope

Category Regulatory Statement
Populations Allowed Children (infants/babies) for the treatment of nappy rash. The product is generally considered suitable for use from birth onwards.
Contraindicated Populations Individuals with known hypersensitivity or allergy to the active ingredients (Titanium Dioxide, Titanium Peroxide, Titanium Salicylate) or any of the excipients in the formulation.
Condition Restrictions Must not be applied to skin that is broken, badly cracked, bleeding, or infected; application is restricted to intact skin surfaces.
Age-Related Rules The product is indicated for the pediatric population. Use in Adults and the Elderly is officially designated as Not applicable in the posology section of the regulatory label.
Pregnancy/Lactation Status Information is documented as Not known or Not applicable in the Summary of Product Characteristics, given the product's intended topical use in the infant population.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official Regulatory Interaction Profile

The official regulatory profile for Metanium Ointment is defined by its classification as a topical preparation intended for external dermal use. Due to its action as a physical barrier and its negligible systemic absorption, the product carries a low risk for interacting with other medicines taken orally or administered systemically.

Interaction Entity Map (High-Level) Official Regulatory Status
Medicinal product categories with documented interactions: None documented.
Specific interacting medicines (if explicitly listed): None documented.
Timing-based interaction rules (if applicable): None documented.
Interaction-related restrictions: None documented.

Resulting Interaction Structure

Official interaction statements:

  • The regulatory documentation confirms that there are no known or reported interactions between Metanium Ointment and other medicinal products.
  • The official product labeling does not include any explicit contraindicated combinations involving co-administration with prescription or non-prescription medicines.
  • The regulatory text does not specify any interactions related to metabolic processes (e.g., CYP enzymes), drug transporters, or pharmacodynamic effects.
  • No mandatory timing rules requiring the separation of administration from other medicinal products are listed in the official documents.

The lack of systemic absorption is the key factor shaping this profile. Accordingly, the authoritative government documents do not specify required restrictions, timing separation rules, or cautions related to food, alcohol, or herbal products.

Mechanism of Action

Physical Isolation and Hydrophobic Barrier

The foundational mechanism relies on the physical blockade exerted by Titanium Dioxide and Titanium Peroxide. These inert compounds deposit onto the stratum corneum, forming a tenacious, highly hydrophobic film. This non-viable barrier physically impedes contact between the skin surface and aqueous irritants or moisture, directly impeding the initiation of the inflammatory cascade driven by contact with irritants.

Chemo-Physical Astringency and Surface Modification

The mechanism is enhanced by the chemo-physical action of Titanium Salicylate, which acts as an astringent. This component causes the gentle precipitation of superficial epithelial proteins, leading to the physiological effect of tissue tightening and drying. This localized modification reduces surface fluid and reduces the conditions conducive to maceration, thereby maintaining the structural integrity necessary for the physical barrier function.

Triple-Action Mechanistic Synergy

The combination product operates through a triple-action synergy to manage the physiochemical processes associated with surface irritation. While the metal oxides provide the essential physical shielding, the salicylate contributes to surface physiochemical regulation and provides minor modulation of localized sensory signaling. The resulting physiological effect is a combined influence resulting in a reduction of irritant exposure and surface fluid content, with efficacy solely dependent on the mechanical integrity of the formed film.

Dosage and Administration Information

Metanium is a combination pharmaceutical product defined as an ointment strictly for topical (cutaneous) application. This preparation contains Titanium Dioxide 20% w/w, Titanium Peroxide 5% w/w, and Titanium Salicylate 3% w/w, and is designated exclusively for external use only.

The official usage pattern is structured around a specific procedural sequence and a high-level frequency schedule. The product is administered via the dermal route, with the instruction to dab a small amount of the ointment onto the affected area. Proper application technique requires the preparation to be spread thinly so that the underlying texture of the skin remains clearly visible through the layer. This detailed procedural step establishes the correct, standardized dose for each application.

The standard dosing frequency is conditional and tied directly to routine care, specified as repeating the application at each nappy change. The instructions for use are targeted toward the pediatric population (infants and young children) for its labeled purpose; official dosing regimens are not applicable to adult or elderly populations. Use is intended to continue until the symptoms subside. If the condition does not show a response to use or if the rash worsens, it is advised to seek medical review. Users should note the practical administration constraint that the product may stain fabrics.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Metanium


Evidence for Use in Diaper Dermatitis (Nappy Rash)

Research for Metanium Ointment, which contains a combination of titanium compounds, has primarily examined the context of Diaper Dermatitis (nappy rash) in infants. Because the product contains long-established ingredients like Titanium Dioxide, the supporting evidence often includes Randomized Controlled Trials (RCTs) conducted for the broader class of protective barrier preparations. The product was studied in research exploring how symptoms change over time; its ingredients were also evaluated in trials focused on short-term or episodic symptom patterns.

Studies explored outcomes linked to inflammatory or irritative states, such as measuring changes in the visual severity of the rash and skin redness (erythema). The populations studied were primarily infants and young children (typically under three years of age) presenting with symptoms of mild to moderate nappy rash. Studies report how symptoms evolved in the observed populations, and research highlights changes measured during the study period. Findings describe patterns observed in the studies related to changes in symptom severity over short time frames.

Research on Other Moisture-Induced Skin Irritation

Research examining the ointment for generalized moisture-induced skin breakdown and chafing is less formalized. Studies explored the physical properties of the ointment, examining its capacity to form a water-repellent seal and its known astringent action. This mechanism was studied for how symptoms change over time in conditions characterized by fluctuating or episodic manifestations. This evidence is often inferred from the data collected for diaper dermatitis.

What is Still Uncertain about Metanium's Evidence Base

The duration of follow-up in the available research is a defining characteristic, with trials typically focusing on short timeframes (often less than two weeks). Long-term effects are not fully established for this product, and studies provide limited insight into whether observed patterns persist. One key research limitation is that comparative evidence is lacking for the specific triple-titanium formulation against other standard single-ingredient barrier creams used in routine care. Data for certain groups, such as older adults, remain insufficient, and evidence quality varies across studies.

Key Studies & References Health Canada: Monograph - Diaper Rash Products (Category IV)

Frequently Asked Questions (FAQ)

Common questions about Metanium (FAQ)

Q: How quickly does Metanium start to work for its intended purpose?

A: Official research supporting the use of Metanium has focused on observing changes in skin symptoms, such as the severity of the rash and redness, over short time frames. However, regulatory documents do not specify a fixed onset-of-action time or a precise time frame for when noticeable changes should occur.

Q: Can Metanium be used on areas of skin other than where it's typically applied?

A: Metanium is strictly defined for external (dermal) application, and its labeled use is targeted toward the pediatric population for nappy rash. Official product information provides no guidance or instruction for use on other skin areas. Studies focusing on generalized moisture-induced skin irritation primarily infer findings from the data collected for the product’s primary indication.

Q: Can Metanium be used on a newborn baby?

A: According to official documentation, the product is indicated for the pediatric population, which includes infants and young children, for its labeled purpose. No specific age constraints are listed within this general category.

Q: What if I apply too much Metanium?

A: Regulatory instructions emphasize that the correct application involves dabbing a small amount onto the affected area and spreading it thinly so the texture of the skin remains visible. The official product documentation does not detail the consequences or necessary steps if an amount greater than the recommended thin application is used.

Q: Is it true that Metanium contains an ingredient that helps block wetness?

A: Yes, the product’s mechanism of action is based on the ingredients Titanium Dioxide and Titanium Peroxide. These compounds are inert and work by forming a highly water-repellent (hydrophobic) film on the skin's surface, which creates a physical barrier against moisture and aqueous irritants.

Q: What is the recommended thickness for applying Metanium?

A: The official instructions for use specify that the preparation must be spread thinly. The goal is that the underlying texture of the skin should remain clearly visible through the layer of ointment, reflecting the application technique described in official labeling.

Q: Is there a maximum number of times per day Metanium can be applied?

A: The standard dosing frequency is linked to routine care, specified as repeating the application at each nappy change. Regulatory documents do not define a numerical maximum number of times per day beyond this conditional instruction.

Q: Can Metanium be used on older children or adults for similar skin concerns?

A: Official dosing regimens are not intended for adult or elderly populations, as the product's use is officially targeted toward infants and young children. Studies focusing on adults for similar skin concerns remain insufficient in authoritative sources.

Q: What's the difference between Metanium and standard nappy rash creams?

A: Official product information defines Metanium as a unique combination product. It contains three active titanium compounds (Titanium Dioxide, Titanium Peroxide, and Titanium Salicylate) intended to provide a triple-action synergy, compared to many single-ingredient barrier preparations.

Q: Are there any known allergic reactions to Metanium?

A: Official documentation lists a formal contraindication for individuals with a known hypersensitivity or allergy to any of its active or inactive ingredients. Skin irritation at the application site is the only adverse reaction specifically listed and is officially classified as very rare.

Q: Why does Metanium have a yellow color?

A: The color of Metanium is a characteristic of its formulation. This is primarily due to the active ingredient Titanium Salicylate, which is known to contribute to a yellow-orange hue, combined with the other base ingredients.

Q: How long can I continue to use Metanium?

A: Use of the product is intended to continue until the symptoms subside. If the condition does not respond to use or if the rash worsens, official regulatory guidance advises seeking medical review.

Q: Is it normal to see a slight residue after using Metanium?

A: The product's mechanism involves forming a tenacious physical film on the skin. While official instructions require the ointment to be spread thinly so the skin’s texture is visible, a visible, water-repellent layer or residue may be present due to the barrier-forming ingredients.

Q: Why do some people use Metanium for concerns other than its main indication?

A: Research has explored the physical properties of the ointment, focusing on its capacity to form a water-repellent seal and its astringent action. This mechanism is studied in the context of generalized moisture-induced skin irritation, which is a common form of skin breakdown.

Q: Are there any specific cleaning instructions for the skin after using Metanium?

A: The regulatory instructions for use specify that the affected area must be cleaned, washed, and dried with a soft towel after removing the soiled nappy, before a fresh application of the ointment is made.

Q: Does using Metanium affect the absorption of other topical products?

A: The product’s mechanism of action relies on creating a tenacious physical barrier on the skin’s surface. While regulatory documents confirm there are no known interactions with medicinal products, the physical barrier may affect the ability of other topical applications to fully contact the skin surface.

Q: Can Metanium stain clothing or bedding?

A: Yes, official regulatory guidance includes a cautionary note that the product may stain fabrics. Regulatory guidance advises avoiding contact with clothing or bedding materials during application.

Q: What are the inactive ingredients in Metanium?

A: According to the official regulatory documents, the inactive ingredients (excipients) used in the formulation are Dimethicone 350, Light Liquid Paraffin, Tincture of Benzoin, and White Soft Paraffin.

Q: Has Metanium been studied in long-term use?

A: The duration of follow-up in the available research is a key characteristic, with clinical trials typically focusing on short timeframes, often less than two weeks. Official sources note that follow-up in available research typically focuses on short timeframes, meaning that data regarding long-term effects are limited.

Q: Is Metanium considered a preventative treatment or a treatment for active concerns?

A: Metanium is officially categorized as a Protectant and Barrier Preparation. Its formulation is used to manage surface irritation through physical shielding and astringent action, which supports the skin’s recovery from irritation.

Q: Is the smell of Metanium considered normal?

A: The characteristic scent of the product is generally considered normal for its formulation. This is due to the presence of Tincture of Benzoin, which is listed as one of the inactive ingredients in the official regulatory documents.

Q: How should the skin look after Metanium has been applied correctly?

A: Correct application involves ensuring the ointment is spread thinly enough so that the underlying texture and color of the skin remain clearly visible through the layer.

Q: What makes Metanium different from barrier creams?

A: Metanium is formally defined as a combination product because it features three active titanium compounds, including Titanium Salicylate. This combination is intended to provide a triple-action synergy, which includes both barrier formation and astringent properties.

Q: Can Metanium cause the skin to become sensitive over time?

A: The documented adverse effects are limited to the application site, with the possibility of skin irritation being officially classified as Very Rare. Regulatory documents do not address potential changes in general skin sensitivity over a long period of time.

Q: What kind of research has been done on the ingredients in Metanium?

A: Research has focused both on the combined product and the properties of its individual components. For example, studies have examined the long-established nature and water-repellent properties of the titanium compounds, as well as the astringent action of Titanium Salicylate.

Q: Why is Metanium often mentioned in online discussions about skin redness?

A: The product has been the subject of research that specifically examines outcomes linked to inflammatory or irritative states. These studies have included measuring and reporting changes in symptoms such as skin redness (erythema) and rash severity.

Q: Can Metanium be used simultaneously with other non-prescription topical treatments?

A: Regulatory documentation states there are no known or reported interactions with other medicinal products. However, because Metanium acts by creating a physical barrier on the skin's surface, a concurrent application may affect the ability of other topical applications to fully contact the skin surface.

Q: Can Metanium be used for general skin irritation?

A: While the product is formally indicated for nappy rash, official research has explored its physical barrier and astringent properties in the context of generalized moisture-induced skin breakdown and chafing. Evidence for these uses is often inferred from the nappy rash data.

Q: Is it possible to be intolerant to one of the inactive ingredients in Metanium?

A: Yes, official regulatory documents state that the preparation is formally contraindicated for individuals with a known hypersensitivity or allergy to any of its active or inactive ingredients.

Q: Does Metanium create a long-lasting barrier on the skin?

A: The mechanism of action is based on forming a tenacious, highly hydrophobic film to block irritants. The product’s instructions, however, structure its use around the need to repeat application at each nappy change.

Q: Are there specific official guidelines on the proper disposal of the empty Metanium tube?

A: Official disposal instructions specify that unused or expired Metanium must be discarded according to local requirements for medicinal products or through official drug take-back schemes. The guidelines do not provide specific, separate instructions for an empty tube.

Q: Does Metanium contain any parabens or preservatives?

A: The official regulatory documents list the inactive ingredients (excipients) as Dimethicone 350, Light Liquid Paraffin, Tincture of Benzoin, and White Soft Paraffin. This list defines the full formulation.

Q: What is the shelf life of Metanium after opening?

A: The official product labeling includes a specific expiry date for the unopened product and emphasizes that the cap must be replaced tightly after each use to maintain stability. A separate, specific shelf life once the product has been opened is not listed in the regulatory documents.

Q: Do any official warnings exist about concurrent use of Metanium with prescription medication?

A: Regulatory documentation confirms that there are no known or reported interactions between Metanium Ointment and other medicinal products, including prescription or non-prescription medicines.

Q: Why is Metanium recommended by some healthcare professionals for skin discomfort?

A: The product is defined by its triple-action synergy, which includes physical shielding against moisture, surface regulation through astringency, and minor localized soothing action, which supports the maintenance of skin health.

How should Metanium be stored and disposed of?

Official Storage and Disposal Instructions

Metanium Ointment must be stored according to specific regulatory requirements to maintain its stability. All storage and disposal information is based strictly on the product's official labeling.

Storage Requirement Labeled Condition
Temperature Store below 25 C (seventy-seven degrees Fahrenheit).
Protection Keep in the original carton to protect from light.
Container Integrity Replace the cap tightly after each use.
Child Safety Keep out of the sight and reach of children.
Stability Limit Do not use the product after the expiry date on the carton/tube.

Regarding disposal, unused or expired Metanium must not be discarded via wastewater or routine household waste. Consumers are instructed to dispose of the product in accordance with local requirements for medicinal products or official drug take-back schemes.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Metanium found in:

A-Z Index: